Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Sales	$ 30,893	$ 37,895
Cost of sales	7,395	9,566
Gross profit	23,498	28,329
Operating expenses:
Selling, general and administrative	31,855	28,636
Research and development	9,472	10,367
Total operating expenses	41,327	39,003
Loss from operations	(17,829)	(10,674)
Other income (expense), net:
Interest expense	(3)	(6)
Interest and other income	1,954	2,508
Loss before income taxes	(15,878)	(8,172)
Income tax expense	6	18
Net loss	(15,884)	(8,190)
Other comprehensive loss
Unrealized loss on short-term investments	(120)	(157)
Foreign currency translation gain	0	6
Total other comprehensive loss	(120)	(151)
Comprehensive loss	$ (16,004)	$ (8,341)
Net loss per share:
Attributable to common stock, basic	$ (0.38)	$ (0.2)
Attributable to common stock, diluted	$ (0.38)	$ (0.2)
Weighted-average shares used in computing net loss per share:
Attributable to common stock, basic	41,306,110	40,509,646
Attributable to common stock, diluted	41,306,110	40,509,646